cyclopentane has been researched along with azomycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, T; Hori, H; Inayama, S; Jin, CZ; Kirk, KL; Kiyoi, S; Nagasawa, H; Nakashima, H; Nakata, E; Nakayama, S; Shimamura, M; Takeuchi, Y; Tanaka, A; Uehara, Y; Uto, Y | 1 |
| Hori, H; Ohkura, K; Tabata, A; Uto, Y | 1 |
2 other study(ies) available for cyclopentane and azomycin
| Article | Year |
|---|---|
Design of antiangiogenic hypoxic cell radiosensitizers: 2-nitroimidazoles containing a 2-aminomethylene-4-cyclopentene-1,3-dione moiety.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Hypoxia; Cell Line; Cell Line, Tumor; Cell Proliferation; Chick Embryo; Cyclopentanes; Drug Design; Mice; Models, Molecular; Nitroimidazoles; Protein Kinase Inhibitors; Radiation-Sensitizing Agents; Rats; Stereoisomerism | 2008 |
Correlation Between Radiosensitizing Activity and the Stereo-structure of the TX-2036 Series of Molecules.
Topics: Cell Hypoxia; Cyclopentanes; Drug Design; Humans; Nitroimidazoles; Radiation Tolerance; Radiation-Sensitizing Agents; Static Electricity; Stereoisomerism; Structure-Activity Relationship | 2019 |